NASDAQ:TGTX

Tg Therapeutics Stock Predictions

etoro logo Buy TGTX
*Your capital is at risk
$40.11
+3.47 (+9.47%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

TGTX Prediction Chart

TGTX Predictions History

Latest community submissions for TGTX.
Predictor Target Session Target Price Result Direction Accuracy Score
Jan 29, 2025 $33.03 -1.27% $33.37 V 98.97% 2
Jan 29, 2025 Bullish $33.37 X 0
Sep 4, 2024 Bullish $22.08 X 0
JS JS Pro
Jun 20, 2024 $16.85 +0.48% $16.98 V 99.23% 3
Jun 20, 2024 $16.47 -1.77% $16.98 X 97.02% 0
Jun 20, 2024 $16.58 -1.10% $16.98 X 97.67% 0
Dec 11, 2023 $15.34 -2.42% $15.21 V 99.15% 3
Dec 11, 2023 $15.48 -1.51% $15.21 V 98.21% 1
Dec 11, 2023 Bullish $15.21 X 0
Sep 25, 2023 $9.39 +2.68% $8.98 X 95.49% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for TGTX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT TG THERAPEUTICS
TG Therapeutics
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hodgkin lymphoma, chronic lymphocytic leukemia (CLL), and relapsing forms of multiple sclerosis; and Umbra...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE